Kelland, L. R. (2000). Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: Current status. Expert opinion on investigational drugs, 9(12), 2903-2911. https://doi.org/10.1517/13543784.9.12.2903
Citace podle Chicago (17th ed.)Kelland, Lloyd R. "Flavopiridol, the First Cyclin-dependent Kinase Inhibitor to Enter the Clinic: Current Status." Expert Opinion on Investigational Drugs 9, no. 12 (2000): 2903-2911. https://doi.org/10.1517/13543784.9.12.2903.
Citace podle MLA (9th ed.)Kelland, Lloyd R. "Flavopiridol, the First Cyclin-dependent Kinase Inhibitor to Enter the Clinic: Current Status." Expert Opinion on Investigational Drugs, vol. 9, no. 12, 2000, pp. 2903-2911, https://doi.org/10.1517/13543784.9.12.2903.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..